Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997–2008

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

(2012) Monica Marta et al.   CNS & Neurological Disorders-Drug Targets

Survival in MS

(2012) D.S. Goodin et al.   NEUROLOGY

Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US

(2012) J. I. Ivanova et al.   JOURNAL OF MEDICAL ECONOMICS

Effect of disease-modifying therapies on brain volume in relapsing–remitting multiple sclerosis: Results of a five-year brain MRI study

(2011) Omar Khan et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A 20-Year Incidence Trend (1989–2008) and Point Prevalence (March 20, 2009) of Multiple Sclerosis in Tehran, Iran: A Population-Based Study

(2011) Seyedeh-Robab Elhami et al.   NEUROEPIDEMIOLOGY

Are the Prevalence and Incidence of Multiple Sclerosis Changing?

(2011) Julián Benito-León   NEUROEPIDEMIOLOGY

Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis

(2010) Hiangkiat Tan et al.   ADVANCES IN THERAPY

Multiple sclerosis survival: a population-based study in Sicily

(2009) P. Ragonese et al.   EUROPEAN JOURNAL OF NEUROLOGY

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation

(2009) PJ Veugelers et al.   Multiple Sclerosis Journal

Population-Based Epidemiological Study of Neurological Diseases in Taiwan: I. Creutzfeldt-Jakob Disease and Multiple Sclerosis

(2009) Chien-Hsu Lai et al.   NEUROEPIDEMIOLOGY

Increasing prevalence and incidence of multiple sclerosis in South East Wales

(2008) C Hirst et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

(2008) N Grytten Torkildsen et al.   Multiple Sclerosis Journal